Galderma Grp logo

Galderma Grp

Stock
Stock
ISIN: CH1335392721
Ticker: GALD
CH1335392721
GALD

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Galderma Grp has so far distributed $0.444 in 2026. The next dividend will be paid on 28.04.2027


$0.351

CHART BY

Frequently asked questions

The market capitalization of Galderma Grp is 35.75B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Galderma Grp is 52.43. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Galderma Grp's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.924. EPS indicates the company's profitability on a per-share basis.
Currently, 20 analysts cover Galderma Grp's stock, with a consensus target price of 249.28. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Galderma Grp reported a revenue of 4.67B.
Galderma Grp's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 1.13B. EBITDA measures the company's overall financial performance.
Galderma Grp has a free cash flow of 825.38M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Galderma Grp employs approximately 7,676 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of Galderma Grp is 184.52M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
35.75B
EPS (TTM) 
$2.924
Free Float 
184.52M
P/E ratio (TTM) 
52.43
Revenue (TTM) 
4.67B
EBITDA (TTM) 
1.13B
Free Cashflow (TTM) 
825.38M

Pricing

1D span
$184.44$188.66
52W span
$163.18$232.87

Analyst Ratings

The price target is 249.28 and the stock is covered by 20 analysts.

Buy

17

Hold

2

Sell

1

Information

Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Employees
7,676
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
CH1335392721
Primary Ticker
GALD

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation